LONDON, Sept. 13, 2021 (GLOBE NEWSWIRE) — Swiss Life Sciences Group (SLSG) continues its enlargement within the CBD market and is proud to announce the launch of its RawSwiss CBD life-style model.
The Swiss Life Sciences Group’s scientific and compliance govt Julija Jacoline explains: “I’ve been engaged on the launch of those CBD oils for nearly two years and am proud to see them coming into the market. I’ve used all my scientific experience and CBD information to create a premium vary of CBD oil merchandise for a variety of holistic and therapeutic makes use of and for normal wellbeing. I’m now working arduous on our upcoming launches of skincare and life-style merchandise, underneath the RawSwiss model and plenty of others that we’re working with, in addition to on some new strategies to get pleasure from CBD in its numerous varieties.”
Within the subsequent few weeks, the RawSwiss model’s web site rawswiss.com might be reside, initially delivering to the Swiss and U.Okay. markets and rolling out its merchandise throughout all European markets by the tip of the yr and the USA in Q1 2022.
All RawSwiss CBD oil merchandise are grown and made in Switzerland, the European CBD hub. Switzerland is on the forefront of the manufacturing of hemp life-style merchandise, driving change as a frontrunner in pioneering prescription drugs.
The Swiss Life Sciences Group controls your entire RawSwiss provide chain; it develops the genes, grows and harvests the vegetation and extracts the cannabinoids, earlier than including them to a large repertoire of formulations for particular wants and outcomes. Swiss Life Sciences Group employs the newest in CO2 and steam extraction to ensure purity you possibly can belief. CO2 cold-press extraction permits Swiss Life Sciences Group to extract all of the cannabinoids from the vegetation, whereas preserving their uncooked and pure properties for skincare and different cosmetics merchandise.
The Swiss Life Sciences Group prides itself that Each RawSwiss product is 100% vegan, gluten and GMO-free, and made with all-natural components.
About The Swiss Life Sciences Group
The Swiss Life Sciences Group S.A. was based to capitalize on the flourishing and ever-evolving hashish and cannabidiol (CBD) sectors, the fastest-growing alternative in life sciences, wellness and healthcare in the present day.
Our imaginative and prescient is to turn out to be a globally trusted model provider of Swiss-based, natural CBD and phytocannabinoid medical merchandise, with manufacturing, manufacturing and certification throughout the EU. Our technique is to rigorously construct Swiss Life Sciences Group into one in every of Europe’s largest seed-to-consumer, vertically built-in enterprise fashions, by means of a sequence of strategic investments, joint ventures, mergers and acquisitions.
Swiss Life Sciences Group Media Contact
For additional info, please contact:
Mrs. Vittoria Fantacci – Director of Communications
Swiss Life Sciences Group PLC
This content material was issued by means of the press release distribution service at Newswire.com.